New eye injection could reduce treatment frequency for wet AMD
Disease control
Recruiting now
This early-stage trial tests a new medicine called EYC-0305, given as an eye injection every 24 weeks, in 30 people aged 50 and older with wet age-related macular degeneration (AMD). The main goal is to check if the treatment is safe and tolerable. Researchers will also measure h…
Phase: PHASE1, PHASE2 • Sponsor: Eyconis INC. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC